Please assess the completion status of the following clinical trial:

Trial Title: Effect and Tolerability of Lactobacillus Rhamnosus GG LA801 for the Preventive Nutritional Care of Nosocomial Diarrhea in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Informed consent signed by the patient's legal guardian(s) for study enrollment;~* Aged 1 to 24 months ;~* Admitted to the hospital for reasons other than diarrhea;~* Stayed in the Short Stay Unit, SSU, for a minimum duration of 6h.~Exclusion Criteria~* With history of gastroenteritis in the 2 weeks before hospitalization;~* With symptoms suggesting an ongoing gastroenteritis or other intestinal disease;~* Use of probiotics or prebiotics within 7 days before admission;~* With immunodeficiency, neoplasm or chronic severe illnesses;~* With a previous hospitalization within 15 days;~* With an history of digestive surgery;~* For whom an oral route is impossible;~* Participating at the same time in another clinical trial.

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 24 Months
- Healthy Volunteers: f

Study Arms:
- Babybiane Imedia (Type: EXPERIMENTAL): Patients receive Babybiane Imedia once daily during seven days.
- Placebo (Type: PLACEBO_COMPARATOR): Patients receive a placebo with the same consistency and taste as the Babybiane Imedia once daily during seven days.

Based on this trial design, predict the completion outcome and termination type (if applicable).